Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factors associated with bleeding events from low molecular weight heparin used in acute coronary syndrome patients
TCTR20171225002Recruiting
- Sponsor
- Chulalongkorn University
- Start
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of low molecular weight heparin calcium in acute coronary syndrome (ACS), sponsored by Chulalongkorn University. Primary endpoint: Bleeding events associated with LMWH use. Started Mar 2018; status: recruiting.
02
Drugs
low molecular weight heparin calcium
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on TCTR20171225002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20171225002.